• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病非透析患者中不恰当使用非甾体抗炎药和其他药物。

Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy.

机构信息

Department of Family Medicine, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.

出版信息

Ren Fail. 2013 Jul;35(6):906-10. doi: 10.3109/0886022X.2013.801272. Epub 2013 Jun 3.

DOI:10.3109/0886022X.2013.801272
PMID:23725334
Abstract

OBJECTIVE

The main goal of chronic kidney disease (CKD) treatment is the prevention of progression of the disease and complications. Inappropriate drug use in patients with CKD is an important issue, which may cause adverse effects on patients and progression of chronic renal failure. The aim of this study is to find the rate of inappropriate drug use among CKD patients.

METHODS

The subjects of this study were selected from the patients with a CKD history of minimum one year, who did not receive renal replacement therapy. Patients were asked to provide a digital record of the drugs they used over the last one year. Individually, for each patient, the drugs that may be contraindicative and that require dose adjustment were identified based on glomerular filtration rate (GFR).

RESULTS

This study includes a total of 185 participants - 97 female (52.4%) and 88 male (47.6%) patients. The average age of patients was 60.50 ± 14.56. It was shown that 149 patients (80.5%) were using inappropriate drugs. Seventy (47.0%) were using one, 79 (53.0%) two, 30 (20/1%) three, and 9 (6.4%) four inappropriate drugs. Of CKD patients, 44.3% were aged 65 or over; and in this age group, inappropriate drug use was more frequent compared to the population below 65 (86.6% vs. 75.7%). The drugs used inappropriately were, respectively, nonsteroidal anti-inflammatory drugs (65.8%), quinolone antibiotics (39.0%), ACE inhibitors (26.9%).

DISCUSSION

Health professionals are required to consider renal functions of all patients, mainly those aged over 65, when administering a treatment.

摘要

目的

慢性肾脏病(CKD)治疗的主要目标是预防疾病进展和并发症。CKD 患者用药不当是一个重要问题,可能会对患者造成不良影响,并导致慢性肾功能衰竭的进展。本研究旨在发现 CKD 患者用药不当的发生率。

方法

本研究的研究对象为至少有一年 CKD 病史且未接受肾脏替代治疗的患者。患者被要求提供过去一年使用的药物的数字记录。单独为每位患者确定可能有禁忌症且需要剂量调整的药物,基于肾小球滤过率(GFR)。

结果

本研究共纳入 185 名参与者,其中女性 97 名(52.4%),男性 88 名(47.6%),患者平均年龄为 60.50±14.56 岁。结果表明,149 名患者(80.5%)正在使用不当药物。70 名(47.0%)患者使用一种,79 名(53.0%)患者使用两种,30 名(20/1%)患者使用三种,9 名(6.4%)患者使用四种不当药物。在 CKD 患者中,44.3%的患者年龄在 65 岁或以上;在这个年龄组中,用药不当的比例高于 65 岁以下的人群(86.6%比 75.7%)。使用不当的药物分别是非甾体抗炎药(65.8%)、喹诺酮类抗生素(39.0%)、ACE 抑制剂(26.9%)。

讨论

在进行治疗时,卫生专业人员需要考虑所有患者的肾功能,尤其是年龄在 65 岁以上的患者。

相似文献

1
Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy.慢性肾脏病非透析患者中不恰当使用非甾体抗炎药和其他药物。
Ren Fail. 2013 Jul;35(6):906-10. doi: 10.3109/0886022X.2013.801272. Epub 2013 Jun 3.
2
Use of nonsteroidal anti-inflammatory drugs and renal failure in nursing home residents-results of the study "Inappropriate Medication in Patients with Renal Insufficiency in Nursing Homes".疗养院居民使用非甾体抗炎药与肾衰竭——“疗养院肾功能不全患者不适当用药”研究结果
Wien Klin Wochenschr. 2016 Apr;128(7-8):287-90. doi: 10.1007/s00508-015-0919-z. Epub 2016 Jan 12.
3
The prevalence of potentially inappropriate medication prescribing in elderly patients with chronic kidney disease.老年慢性肾脏病患者潜在不适当药物处方的流行情况。
Postgrad Med J. 2013 May;89(1051):247-50. doi: 10.1136/postgradmedj-2012-130889. Epub 2013 Feb 16.
4
Reducing inappropriate non-steroidal anti-inflammatory prescription in primary care patients with chronic kidney disease.减少慢性肾病初级护理患者不适当的非甾体抗炎药处方。
Int J Health Care Qual Assur. 2017 Aug 14;30(7):638-644. doi: 10.1108/IJHCQA-09-2016-0145.
5
Association between chronic kidney disease and synergistic, potentially nephrotoxic medication use in elderly hospitalized patients: A single-center cross-sectional study
.
Int J Clin Pharmacol Ther. 2019 Jul;57(7):353-361. doi: 10.5414/CP203429.
6
Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.肾病饮食改良法与Cockcroft-Gault方程在抗菌药物给药剂量计算方面的比较。
Pharmacotherapy. 2009 Jun;29(6):649-55. doi: 10.1592/phco.29.6.649.
7
A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.炎性关节病患者肾功能障碍的对比研究:与心血管疾病密切相关,与抗风湿治疗、炎症标志物或关节炎持续时间无关。
Int J Rheum Dis. 2011 Aug;14(3):255-60. doi: 10.1111/j.1756-185X.2011.01594.x. Epub 2011 Apr 4.
8
Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.在开始慢性肾脏替代治疗之前使用非甾体抗炎药:一项全国性研究。
Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):428-34. doi: 10.1002/pds.3227. Epub 2012 Feb 17.
9
Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.台湾慢性肾脏病多学科护理的效果:一项为期 3 年的前瞻性队列研究。
Nephrol Dial Transplant. 2013 Mar;28(3):671-82. doi: 10.1093/ndt/gfs469. Epub 2012 Dec 6.
10
Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.影响选择不接受透析的晚期慢性肾病患者生存的因素。
Ren Fail. 2007;29(6):653-9. doi: 10.1080/08860220701459634.

引用本文的文献

1
Nephroprotective activity of Eysenhardtia polystachya through antioxidant, HS, and NO pathways.多穗艾森豆通过抗氧化、HS和NO途径的肾保护活性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 12. doi: 10.1007/s00210-025-04331-4.
2
The prevalence and contributing factors of NSAIDs prescription among chronic kidney disease patients in primary care: a mixed methods study from Kingdom of Bahrain.初级保健中慢性肾病患者非甾体抗炎药处方的患病率及影响因素:来自巴林王国的一项混合方法研究
BMC Prim Care. 2025 Apr 17;26(1):116. doi: 10.1186/s12875-025-02817-x.
3
Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan.
巴基斯坦一家三级护理医院慢性肾脏病患者不适当高剂量的模式、频率和相关因素。
BMC Nephrol. 2023 May 1;24(1):118. doi: 10.1186/s12882-023-03167-5.
4
Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARY.非甾体抗炎药能否安全用于慢性肾脏病患者的镇痛?:评论
Kidney360. 2020 Sep 23;1(11):1192-1194. doi: 10.34067/KID.0004652020. eCollection 2020 Nov 25.
5
Analysis of the association between emergency dialysis start in patients with end-stage kidney disease and non-steroidal anti-inflammatory drugs, proton-pump inhibitors, and iodinated contrast agents.分析终末期肾病患者急诊透析开始与非甾体抗炎药、质子泵抑制剂和碘造影剂之间的关联。
J Nephrol. 2021 Oct;34(5):1711-1723. doi: 10.1007/s40620-020-00952-5. Epub 2021 Apr 20.
6
A systematically collated library of prescribing safety indicators for people with chronic kidney disease.一个系统整理的针对慢性肾病患者的处方安全指标库。
BMC Nephrol. 2020 Nov 18;21(1):493. doi: 10.1186/s12882-020-02158-0.
7
Use of renal risk drugs in a nation-wide Polish older adult population: an analysis of PolSenior database.在波兰全国老年人群体中使用肾脏风险药物:PolSenior 数据库分析。
BMC Geriatr. 2019 Mar 5;19(1):70. doi: 10.1186/s12877-019-1075-5.
8
Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study.慢性肾病患者使用非甾体抗炎药的一项流行病学研究。
J Egypt Public Health Assoc. 2019;94(1):8. doi: 10.1186/s42506-018-0005-2. Epub 2019 Jan 30.
9
Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.慢性肾病患者高风险药物的处方:来自华盛顿、怀俄明、阿拉斯加、蒙大拿和爱达荷地区实践与研究网络的一项横断面研究。
Fam Pract. 2018 Sep 18;35(5):589-594. doi: 10.1093/fampra/cmy001.
10
Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital.中国一家三级教学医院中未接受透析治疗的慢性肾脏病患者用药处方的不合理性。
Ther Clin Risk Manag. 2016 Oct 12;12:1517-1524. doi: 10.2147/TCRM.S116789. eCollection 2016.